NASDAQ
ARWR

Arrowhead Pharmaceuticals Inc

SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
TRADE & SERVICES

Prices are adjusted according to historical splits.

Arrowhead Pharmaceuticals Inc Stock Price

Vitals

Today's Low:
$34.5600
Today's High:
$37.0700
Open Price:
$35.4500
52W Low:
$26.81
52W High:
$84.83
Prev. Close:
$35.5200
Volume:
848001

Company Statistics

Market Cap.:
$3.663 billion
Book Value:
4.291
Revenue TTM:
$0.250 billion
Operating Margin TTM:
-63.8%
Gross Profit TTM:
$0.138 billion
Gross Profit TTM:
$0.138 billion
Profit Margin:
-61.6%
Return on Assets TTM:
-13.4%
Return on Equity TTM:
-33.8%

Company Profile

Arrowhead Pharmaceuticals Inc had its IPO on 1997-01-06 under the ticker symbol ARWR.

The company operates in the TRADE & SERVICES sector and SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry. Arrowhead Pharmaceuticals Inc has a staff strength of 0 employees.

Stock update

Shares of Arrowhead Pharmaceuticals Inc opened at $35.45 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $34.56 - $37.07, and closed at $34.61.

This is a -2.56% slip from the previous day's closing price.

A total volume of 848,001 shares were traded at the close of the day’s session.

In the last one week, shares of Arrowhead Pharmaceuticals Inc have increased by +4.88%.

Arrowhead Pharmaceuticals Inc's Key Ratios

Arrowhead Pharmaceuticals Inc has a market cap of $3.663 billion, indicating a price to book ratio of 8.36 and a price to sales ratio of 14.66.

In the last 12-months Arrowhead Pharmaceuticals Inc’s revenue was $0.250 billion with a gross profit of $0.138 billion and an EBITDA of $-0.149 billion. The EBITDA ratio measures Arrowhead Pharmaceuticals Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Arrowhead Pharmaceuticals Inc’s operating margin was -63.8% while its return on assets stood at -13.4% with a return of equity of -33.8%.

In Q2, Arrowhead Pharmaceuticals Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 29.4%.

Arrowhead Pharmaceuticals Inc’s PE and PEG Ratio

Forward PE
111.11
Trailing PE
-
PEG
-1.32

Its diluted EPS in the last 12-months stands at $-1.075 per share while it has a forward price to earnings multiple of 111.11 and a PEG multiple of -1.32. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Arrowhead Pharmaceuticals Inc’s profitability.

Arrowhead Pharmaceuticals Inc stock is trading at a EV to sales ratio of 13.85 and a EV to EBITDA ratio of -23.19. Its price to sales ratio in the trailing 12-months stood at 14.66.

Arrowhead Pharmaceuticals Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Arrowhead Pharmaceuticals Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Arrowhead Pharmaceuticals Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Arrowhead Pharmaceuticals Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Arrowhead Pharmaceuticals Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Arrowhead Pharmaceuticals Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$34.61
52-Week High
$84.83
52-Week Low
$26.81
Analyst Target Price
$73.92

Arrowhead Pharmaceuticals Inc stock is currently trading at $34.61 per share. It touched a 52-week high of $84.83 and a 52-week low of $84.83. Analysts tracking the stock have a 12-month average target price of $73.92.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Arrowhead Pharmaceuticals Inc

The stock symbol (also called stock or share ticker) of Arrowhead Pharmaceuticals Inc is ARWR

The IPO of Arrowhead Pharmaceuticals Inc took place on 1997-01-06

Similar Industry Stocks (SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH)

Last Price
Chg
Chg%
$0.14
-0.01
-4.24%
Exelixis Inc (EXEL)
$17.01
0.21
+1.25%
$1.02
-0.04
-3.77%
$1.48
-0.1
-6.33%
$1.63
-0.15
-8.43%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
$0.02
0.01
+100%
Oi S.A (OIBR-C)
$0
0
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Arrowhead Pharmaceuticals, Inc. develops drugs for the treatment of intractable diseases in the United States. The company is headquartered in Pasadena, California.

Address

225 SOUTH LAKE AVENUE, SUITE 1050, PASADENA, CA, US